Deepa Pakianathan leads all biotech investing at Delphi Ventures while simultaneously serving as CEO and founder of her own stealth oncology company, giving her current operator experience alongside her investing role. She is recognized as a thought leader on designing best-in-class immuno-oncology antibody-drug conjugates and regularly participates in high-level policy conversations, including conducting a public fireside chat with former FDA Commissioner Scott Gottlieb. Deepa Pakianathan leads all biotech investing at Delphi Ventures while simultaneously serving as CEO and founder of her own stealth oncology company, giving her current operator experience alongside her investing role. She is recognized as a thought leader on designing best-in-class immuno-oncology antibody-drug conjugates and regularly participates in high-level policy conversations, including conducting a public fireside chat with former FDA Commissioner Scott Gottlieb.